(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium has been researched along with Glioma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Felgner, PL; Hanisch, UK; Reszka, R; Zhang, L; Zhu, J | 1 |
1 other study(ies) available for (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and Glioma
Article | Year |
---|---|
A continuous intracerebral gene delivery system for in vivo liposome-mediated gene therapy.
Topics: Animals; Antiviral Agents; Brain Neoplasms; Cell Survival; DNA, Viral; Ganciclovir; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Glioma; Humans; Lac Operon; Lipids; Liposomes; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Rats; Rats, Inbred F344; Simplexvirus; Stereotaxic Techniques; Thymidine Kinase | 1996 |